M&A Deal Summary

Northwest Biotherapeutics Acquires Flaskworks

On September 1, 2020, Northwest Biotherapeutics acquired medical products company Flaskworks for 4M USD

Acquisition Highlights
  • This is Northwest Biotherapeutics’ 1st transaction in the Medical Products sector.
  • This is Northwest Biotherapeutics’ largest (disclosed) transaction.
  • This is Northwest Biotherapeutics’ 1st transaction in the United States.
  • This is Northwest Biotherapeutics’ 1st transaction in Massachusetts.

M&A Deal Summary
Date 2020-09-01
Target Flaskworks
Sector Medical Products
Buyer(s) Northwest Biotherapeutics
Deal Type Add-on Acquisition
Deal Value 4M USD

Target

Flaskworks

Boston, Massachusetts, United States
Flaskworks LLC is a manufacturer of immune cell therapies (including T cell therapies and others). Flaskworks is based in Boston, Massachusetts.

Search 201,157 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Northwest Biotherapeutics

Bethesda, Maryland, United States
Category Company
Sector Life Science
DESCRIPTION

Northwest Biotherapeutics, Inc. is a biotechnology company focused on developing personalized immunotherapy products designed to treat cancers more effectively than current treatments, without toxicities of the kind associated with chemotherapies, and on a cost-effective basis, in both North America and Europe.

DEAL STATS #
Overall 1 of 1
Sector (Medical Products) 1 of 1
Type (Add-on Acquisition) 1 of 1
State (Massachusetts) 1 of 1
Country (United States) 1 of 1
Year (2020) 1 of 1
Size (of disclosed) 1 of 1
Mergr

Product

Company

Legal